215 related articles for article (PubMed ID: 11650684)
61. Genetic engineering: regulation issue is resurrected by EPA.
Budiansky S
Nature; 1983 Aug; 304(5927):572. PubMed ID: 11653487
[TBL] [Abstract][Full Text] [Related]
62. Report urges freedom for genetic engineers.
New Sci; 1981 Apr; 90(1247):8. PubMed ID: 11664138
[No Abstract] [Full Text] [Related]
63. Recombinant DNA Advisory Committee: minutes of meeting, 14 Jan 1993.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1993 Aug; 4(4):529-44. PubMed ID: 11643161
[No Abstract] [Full Text] [Related]
64. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
Karny GM
Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588
[No Abstract] [Full Text] [Related]
65. Human Gene Therapy Subcommittee: minutes of meeting, 5 Apr 1991.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee
Hum Gene Ther; 1992 Apr; 3(2):233-48. PubMed ID: 11643022
[No Abstract] [Full Text] [Related]
66. Biotechnology regulation: White House holds the ring.
Beardsley T
Nature; 1985 Jan; 313(5998):85. PubMed ID: 11653580
[TBL] [Abstract][Full Text] [Related]
67. Guide to planning human gene therapy.
Miller JA
Sci News; 1985 Feb; 127(5):71. PubMed ID: 11653569
[No Abstract] [Full Text] [Related]
68. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
Barkstrom JE
Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
[No Abstract] [Full Text] [Related]
69. Federal embryo research is backed: ethicists see benefits overriding qualms.
Weiss R
Washington Post; 1999 May; ():A1, A16. PubMed ID: 11648116
[No Abstract] [Full Text] [Related]
70. Molecular biology or molecular politics? The production of scientific consensus on the hazards of recombinant DNA technology.
Wright S
Soc Stud Sci; 1986 Nov; 16(4):593-620. PubMed ID: 11650809
[No Abstract] [Full Text] [Related]
71. Minutes of meetings, 31 Jul 1990 16 Oct 1990.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1991; 2(2):177-91. PubMed ID: 11642903
[No Abstract] [Full Text] [Related]
72. Recombinant DNA research: proposed actions under guidelines.
US National Institutes of Health
Fed Regist; 1984 Sep; 49(184):37016-7. PubMed ID: 11645519
[No Abstract] [Full Text] [Related]
73. Federal policy for the protection of human subjects; notice and proposed rules.
U.S. Office of Science and Technology Policy
Fed Regist; 1988 Nov; 53(218):45660-82. PubMed ID: 11645617
[No Abstract] [Full Text] [Related]
74. Health chief assails a research deal.
Hilts PJ
N Y Times Web; 1993 Mar; ():A12. PubMed ID: 11646979
[No Abstract] [Full Text] [Related]
75. Court rules against gene-splice field test.
Miller JA
Sci News; 1984 May; 125(21):325. PubMed ID: 11653546
[No Abstract] [Full Text] [Related]
76. Minutes of meeting of the Human Gene Therapy Subcommittee, 30 Mar 1990.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommitttee
Hum Gene Ther; 1990; 1(4):481-91. PubMed ID: 11642815
[No Abstract] [Full Text] [Related]
77. The double helix of self-interest.
Simring FR
Sciences (New York); 1977; 17(3):10-13+. PubMed ID: 11661478
[No Abstract] [Full Text] [Related]
78. Minutes of meeting, 4 Feb 1991.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1991; 2(4):397-413. PubMed ID: 11642961
[No Abstract] [Full Text] [Related]
79. Recombinant DNA Advisory Committee: minutes of meeting, 12-13 Sep 1994.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1995 Apr; 6(4):481-525. PubMed ID: 11644708
[No Abstract] [Full Text] [Related]
80. A legal perspective on the control of the technology of genetic engineering.
Cripps YM
Mod Law Rev; 1981 Jul; 44(4):369-87. PubMed ID: 11650549
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
